ENTITY
Lupin

Lupin (LPC IN)

279
Analysis
Health Care • India
Lupin is an Indian multinational pharmaceutical company that develops, manufactures, and markets a diverse range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company specializes in therapeutic areas such as cardiovascular, anti-diabetic, respiratory, anti-infective, and women's health. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
more
•02 Sep 2025 20:37•Broker

Axis Intellect - Aggressive

Stock investment endeavours to deliver consistent outperformance in the long term by making a diversified investment of ‘Winners’.

Logo
335 Views
Share
•24 Aug 2025 08:32•Broker

Quarterly Flipbook: Earnings growth and downgrade cycle bottoming-out

The aggregate performance of the Q1FY26 earnings season was steady as sequential improvement in YoY PAT growth continued in the current quarter

Logo
295 Views
Share
•13 Aug 2025 05:11•Broker

Pharmaceuticals: IPM: 7% value and 2% unit decline in Jul-25

As per IQVIA, IPM saw 7.1% YoY growth in Jul-25 on a high base of 11.7% growth in Jul-24 (~11.5% YoY in Jun’25, 9% YoY in Q1FY26, and 8% in FY25)...

Logo
216 Views
Share
•08 Aug 2025 06:39•Broker

HSIE Results Daily: Bajaj Auto, Trent, Lupin, Prestige Estates, Berger Paints...

Bajaj Auto: The company continues to face headwinds in its key export market, NigeriaWhile currency tailwinds should aid the rest of the exports,...

Logo
283 Views
Share
•15 Jul 2025 05:00•Broker

Pharmaceuticals: IPM: 11.5% value and 5% unit growth in Jun’25

As per IQVIA, IPM saw a strong growth for Jun’25 at 11.5% YoY (vs 7% in Apr’25 and FY25, +7% YoY in Jun’24) with 5% YoY growth in units

Logo
249 Views
Share
x